COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

CALM-2

Purpose of Study

Evaluate the safety and effectiveness of the MobiusHD System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal study. Patients with resistant hypertension who remain uncontrolled despite pharmacologic treatment with maximum tolerated, guideline-directed anti-hypertensive pharmacologic therapy will be evaluated.

Trial Status

On hold

Eligibility Criteria

  • 18-80 years old
  • mean 24 hour ambulatory systolic blood pressure >145 mmHG and <mmHG

Duration of Participation

Approximately 5 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: jyoung@iowaheart.com